Search
Real-World Evidence: Navigating Preeclampsia with Angiogenic Biomarkers
Webinar October 2024 (1 hour)
In this webinar, Dr. Sarosh Rana shares insights on the clinical implementation of the sFlt-1/PlGF biomarker test at the University of Chicago, highlighting outcomes from the BEACON study to demonstrate how the test can help optimize risk assessment, guide treatment decisions, and safely prolong pregnancies when managing preeclampsia.
Speaker
Sarosh Rana, MD, MPH, FACOG
Professor of Obstetrics and Gynecology Section Chief, Maternal-Fetal Medicine
Chief Obstetrical Transformation Officer
University of Chicago Medicine
Learning objectives
- Discuss implementation of the sFlt-1/PlGF biomarker test in clinical practice at University of Chicago hospitals.
- Understand the significant benefits of the sFlt-1/PlGF biomarker test in preeclampsia management, as supported by real-world evidence (BEACON study).
- Explore the value of the sFlt-1/PlGF test in assessing the risk of developing severe preeclampsia within a two-week timeframe, and how it can effectively contribute to safely prolonging pregnancies.
- Demonstrate the biomarker test’s ability to optimize treatment decisions and provide more precise and effective management of preeclampsia, particularly in situations of uncertainty or non-specific laboratory results.
Thermo Fisher Scientific products are distributed globally and their uses, applications, indications, claims and availability of products in each country depend on local regulatory marketing authorization status, please consult the Instructions For Use (IFU) available in your country.
© 2025 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. B·R·A·H·M·S is a registered trademark of B·R·A·H·M·S GmbH.